$211.04
1.33% yesterday
NYSE, Nov 04, 10:00 pm CET

IQVIA Stock price

$210.96
+5.94 2.90% 1M
+58.66 38.52% 6M
+14.45 7.35% YTD
+0.77 0.37% 1Y
+6.86 3.36% 3Y
+40.06 23.44% 5Y
+145.14 220.51% 10Y
+168.85 400.97% 20Y
NYSE, Closing price Tue, Nov 04 2025
-2.92 1.37%

New AI Insights on IQVIA Insights AI Insights on IQVIA

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
$35.9b
Enterprise Value
$48.9b
Net debt
$13.0b
Cash
$2.0b
Shares outstanding
170.3m
Valuation (TTM | estimate)
P/E
28.2 | 17.6
P/S
2.3 | 2.2
EV/Sales
3.1 | 3.0
EV/FCF
22.1
P/B
5.8
Financial Health
Equity Ratio
22.6%
Return on Equity
22.6%
ROCE
11.2%
ROIC
9.0%
Debt/Equity
2.4
Financials (TTM | estimate)
Revenue
$15.9b | $16.3b
EBITDA
$3.4b | $3.8b
EBIT
$2.3b | $3.1b
Net Income
$1.3b | $2.0b
Free Cash Flow
$2.2b
Growth (TTM | estimate)
Revenue
3.9% | 6.0%
EBITDA
2.9% | 12.8%
EBIT
4.3% | 35.5%
Net Income
-8.7% | 48.7%
Free Cash Flow
12.8%
Margin (TTM | estimate)
Gross
33.8%
EBITDA
21.3% | 23.4%
EBIT
14.2%
Net
8.1% | 12.5%
Free Cash Flow
13.9%
More
EPS
$7.5
FCF per Share
$13.0
Short interest
3.2%
Employees
88k
Rev per Employee
$180.0k
Show more

Is IQVIA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,031 stocks worldwide.

IQVIA Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a IQVIA forecast:

24x Buy
83%
5x Hold
17%

Analyst Opinions

29 Analysts have issued a IQVIA forecast:

Buy
83%
Hold
17%

Financial data from IQVIA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
15,904 15,904
4% 4%
100%
- Direct Costs 10,532 10,532
6% 6%
66%
5,372 5,372
0% 0%
34%
- Selling and Administrative Expenses 1,984 1,984
5% 5%
12%
- Research and Development Expense - -
-
-
3,388 3,388
3% 3%
21%
- Depreciation and Amortization 1,130 1,130
0% 0%
7%
EBIT (Operating Income) EBIT 2,258 2,258
4% 4%
14%
Net Profit 1,283 1,283
9% 9%
8%

In millions USD.

Don't miss a Thing! We will send you all news about IQVIA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IQVIA Stock News

Neutral
Seeking Alpha
8 days ago
IQVIA Holdings Inc. (NYSE:IQV ) Q3 2025 Earnings Call October 28, 2025 9:00 AM EDT Company Participants Kerri Joseph - SVP of Investment Relation & Treasury Ari Bousbib - CEO & Chairman Ronald Bruehlman - Executive VP & CFO Michael Fedock - Senior Vice President of Financial Planning and Analysis Conference Call Participants David Windley - Jefferies LLC, Research Division Justin Bowers - Deuts...
Negative
Reuters
8 days ago
IQVIA Holdings on Tuesday narrowed its annual profit forecast, trimming the upper end of its outlook, as it expects cancellations of research contracts from pharmaceutical clients to persist into the second half of this year.
Neutral
Business Wire
8 days ago
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended September 30, 2025. Third-Quarter 2025 Operating Results Revenue for the third quarter of $4,100 mil...
More IQVIA News

Company Profile

Provides biopharmaceutical development services and commercial outsourcing services

Head office United States
CEO Ari Bousbib
Employees 88,000
Founded 1950
Website ir.iqvia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today